{"Ticker": "TFX", "Company": "Teleflex", "Sector": "Health Care", "Updated": "2022-07-06", "Rating": [{"Date": "2022-07-06", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$300"}, {"Date": "2022-05-09", "Rating": "Initiated", "Organization": "BofA Securities", "Rating_Change": "Neutral", "Target_Change": "$315"}, {"Date": "2022-04-13", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Hold", "Target_Change": "$370"}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$431 to $383"}, {"Date": "2022-01-04", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$465 to $325"}, {"Date": "2021-12-10", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Outperform", "Target_Change": "$415"}, {"Date": "2021-10-07", "Rating": "Downgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Overweight to Sector Weight", "Target_Change": ""}, {"Date": "2021-09-07", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Outperform", "Target_Change": "$440"}, {"Date": "2021-07-19", "Rating": "Downgrade", "Organization": "SVB Leerink", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": "$410"}, {"Date": "2021-01-06", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$406 to $445"}, {"Date": "2020-11-02", "Rating": "Upgrade", "Organization": "KeyBanc Capital Markets", "Rating_Change": "Sector Weight to Overweight", "Target_Change": "$382"}, {"Date": "2020-01-31", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$408 to $423"}, {"Date": "2019-08-02", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$325 to $403"}, {"Date": "2019-06-11", "Rating": "Initiated", "Organization": "Wells Fargo", "Rating_Change": "Outperform", "Target_Change": "$345"}, {"Date": "2019-04-24", "Rating": "Downgrade", "Organization": "Needham", "Rating_Change": "Strong Buy to Buy", "Target_Change": "$325"}, {"Date": "2019-02-22", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Strong Buy", "Target_Change": "$300 to $325"}, {"Date": "2018-10-16", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Equal Weight", "Target_Change": "$266"}, {"Date": "2018-09-10", "Rating": "Upgrade", "Organization": "Needham", "Rating_Change": "Buy to Strong Buy", "Target_Change": "$279 to $300"}, {"Date": "2018-08-03", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$298 to $279"}, {"Date": "2018-05-14", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$293 to $298"}, {"Date": "2018-05-04", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$285 to $293"}, {"Date": "2018-04-04", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Neutral", "Target_Change": "$257"}, {"Date": "2017-11-10", "Rating": "Resumed", "Organization": "Piper Jaffray", "Rating_Change": "Overweight", "Target_Change": "$295"}, {"Date": "2017-11-03", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Buy", "Target_Change": "$237 to $285"}, {"Date": "2017-09-08", "Rating": "Upgrade", "Organization": "Leerink Partners", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": ""}]}